Ligand id: 6933

Name: gantenerumab

No information available.
Summary of Clinical Use
May be useful in the treatment of Alzheimer's disease [3]. In phase I trials treatment caused reduced brain amyloid β levels, but was associated with the unwanted side effect of vasogenic edema. Phase III trial is underway with results expected in 2015.